News

Filter

1 to 9 of 10 results

Shire settles with Actavis/Watson over Intuniv; Lilly sues J&J

26-04-2013

Ireland-headquartered Shire (LSE: SHP) says it has settled all pending litigation with Actavis (NYSE:…

ActavisEli LillyGenericsIntunivJohnson & JohnsonNeurologicalNorth AmericaPatentsPharmaceuticalShiresolanezumabWatson Pharmaceuticals

US FDA approves generics for Actavis and Lupin

06-07-2012

Switzerland-based generic drugmaker Actavis Group, now owned by US firm Watson Pharmaceuticals (NYSE:…

ActavisGenericsIntunivLupinLyricaNeurologicalNorth AmericaPfizerRegulationShireWatson Pharmaceuticals

Shire to face generic competition for Adderall XR from Actavis

25-06-2012

Shares in UK drugmaker Shire (LSE: SHP) fell around 9% to £17.82 in early trading this morning,…

ActavisAdderall XRGenericsNeurologicalNorth AmericaPharmaceuticalRegulationShireWatson Pharmaceuticals

Upbeat news for Shire as FDA delays labeling decision on ADHA drugs; firm sues Watson

11-04-2011

In what was largely viewed as positive news for Ireland headquartered Shire (LSE: SHP), the Food and…

AdderallShireVyvanseWatson Pharmaceuticals

Elan and Celgene settle over Abraxane; Watson re-challenges Shire Adderall XR patent

28-02-2011

Ireland-based Elan (NYSE: ELN) says a subsidiary has entered into a settlement and license agreement…

AbraxaneAdderall XRCelgeneElanGenericsNeurologicalNorth AmericaOncologyPatentsPharmaceuticalShireWatson Pharmaceuticals

Shire files suit against Impax and Watson over Intuniv patent

06-12-2010

Ireland-headquartered specialty pharma firm Shire plc (LSE: SHP) has filed a lawsuit in the US District…

Impax LaboratoriesIntunivLegalNeurologicalNorth AmericaPatentsPharmaceuticalShireWatson Pharmaceuticals

Generic success sparks further competition

20-05-2002

As generic drug companies are increasing their success, brand-name drugmakers are now facing stiffer…

AdderallAmphetamineBarr LaboratoriesBusparBuspironeDextroamphetamine Mixed SaltsFluoxetine HclMylan LaboratoriesProzacShireWatson Pharmaceuticals

Medeva shares jump on merger talks

09-09-1999

Shares in UK drugmaker Medeva soared 24.7% to close at L1.64 ($2.63) onSeptember 8 after the company…

Hepatitis B VaccineRecombivaxShireWatson Pharmaceuticals

1 to 9 of 10 results

COMPANY SPOTLIGHT

Menarini

Back to top